NortonLifeLock (NASDAQ:NLOK) Earns Buy Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of NortonLifeLock (NASDAQ:NLOK – Free Report) in a research report sent to investors on Tuesday morning. The brokerage issued a buy rating on the stock. NortonLifeLock Price Performance Shares of NortonLifeLock stock opened at $22.27 on Tuesday. NortonLifeLock has a 1 year low of $20.12 and a 1 year high […]

Leave a Reply

Your email address will not be published.

Previous post Oncternal Therapeutics (NASDAQ:ONCT) Upgraded to “Buy” at Brookline Capital Management
Next post Mirati Therapeutics (NASDAQ:MRTX) Earns Sell Rating from Analysts at StockNews.com